NCT04019743 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 28, 2019

Primary Completion Date

August 30, 2019

Study Completion Date

September 4, 2019

Conditions

HypertensionDyslipidemias

Interventions

DRUG

CKD-330 16/10mg Tab. 1T and D086 Tab. 1T

single oral administration under fasting condition

DRUG

CKD-333 16/10/40mg formulation 1 Tab. 1T

single oral administration under fasting condition

DRUG

CKD-333 16/10/40mg formulation 2 Tab. 1T

single oral administration under fasting condition

Trial Locations (1)

Chonbuk National University Hospital, Jeonju, South Korea